Quarterly report pursuant to Section 13 or 15(d)

Acquisition of Emerald Health Therapeutics, Inc. (Details)

v3.23.1
Acquisition of Emerald Health Therapeutics, Inc. (Details)
3 Months Ended
Feb. 09, 2023
Nov. 10, 2022
USD ($)
installment
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Business Acquisition [Line Items]        
Wind-down costs     $ 383,109 $ 0
Emerald Health Therapeutics, Inc.        
Business Acquisition [Line Items]        
Wind-down costs     307,000  
Discontinued Operations, Disposed of by Sale | Verdelite SPA        
Business Acquisition [Line Items]        
Aggregate purchase price   $ 9,385,064    
Non-refundable deposit   553,800    
Amount paid   5,532,266    
Loss on sale     $ 307,086  
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Disposal Group, Tranche One        
Business Acquisition [Line Items]        
Amount paid   $ 369,200    
Number of installments | installment   5    
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Disposal Group, Tranche Two        
Business Acquisition [Line Items]        
Amount paid   $ 2,769,000    
Number of installments | installment   3    
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Installment Term One        
Business Acquisition [Line Items]        
Installment term 18 months      
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Installment Term Two        
Business Acquisition [Line Items]        
Installment term 30 months      
Discontinued Operations, Disposed of by Sale | Verdelite SPA | Installment Term Three        
Business Acquisition [Line Items]        
Installment term 42 months